BIOQ
Price
$44.25
Change
-$0.75 (-1.67%)
Updated
Jun 5 closing price
Capitalization
5.24M
BMXMF
Price
$142.45
Change
-$1.02 (-0.71%)
Updated
Jun 12 closing price
Capitalization
12.68B
Interact to see
Advertisement

BIOQ vs BMXMF

Header iconBIOQ vs BMXMF Comparison
Open Charts BIOQ vs BMXMFBanner chart's image
BIOQUAL
Price$44.25
Change-$0.75 (-1.67%)
Volume$212
Capitalization5.24M
Biomerieux 69 Marcy L'Etoile
Price$142.45
Change-$1.02 (-0.71%)
Volume$10
Capitalization12.68B
BIOQ vs BMXMF Comparison Chart in %
Loading...
BIOQ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BMXMF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BIOQ vs. BMXMF commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIOQ is a Hold and BMXMF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (BIOQ: $44.25 vs. BMXMF: $142.45)
Brand notoriety: BIOQ and BMXMF are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BIOQ: 29% vs. BMXMF: 39%
Market capitalization -- BIOQ: $5.24M vs. BMXMF: $12.68B
BIOQ [@Medical Specialties] is valued at $5.24M. BMXMF’s [@Medical Specialties] market capitalization is $12.68B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BIOQ’s FA Score shows that 2 FA rating(s) are green whileBMXMF’s FA Score has 1 green FA rating(s).

  • BIOQ’s FA Score: 2 green, 3 red.
  • BMXMF’s FA Score: 1 green, 4 red.
According to our system of comparison, BMXMF is a better buy in the long-term than BIOQ.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BIOQ’s TA Score shows that 2 TA indicator(s) are bullish while BMXMF’s TA Score has 3 bullish TA indicator(s).

  • BIOQ’s TA Score: 2 bullish, 1 bearish.
  • BMXMF’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, BMXMF is a better buy in the short-term than BIOQ.

Price Growth

BIOQ (@Medical Specialties) experienced а 0.00% price change this week, while BMXMF (@Medical Specialties) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +2.37%. For the same industry, the average monthly price growth was +1.94%, and the average quarterly price growth was +2.76%.

Industries' Descriptions

@Medical Specialties (+2.37% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BMXMF($12.7B) has a higher market cap than BIOQ($5.24M). BMXMF YTD gains are higher at: 34.146 vs. BIOQ (-33.056). BMXMF has higher annual earnings (EBITDA): 862M vs. BIOQ (6.08M). BMXMF has more cash in the bank: 553M vs. BIOQ (3.76M). BMXMF has higher revenues than BIOQ: BMXMF (3.59B) vs BIOQ (35.9M).
BIOQBMXMFBIOQ / BMXMF
Capitalization5.24M12.7B0%
EBITDA6.08M862M1%
Gain YTD-33.05634.146-97%
P/E RatioN/A25.51-
Revenue35.9M3.59B1%
Total Cash3.76M553M1%
Total DebtN/A505M-
FUNDAMENTALS RATINGS
BIOQ vs BMXMF: Fundamental Ratings
BIOQ
BMXMF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
12
Undervalued
21
Undervalued
PROFIT vs RISK RATING
1..100
10095
SMR RATING
1..100
572
PRICE GROWTH RATING
1..100
8541
P/E GROWTH RATING
1..100
7440
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BIOQ's Valuation (12) in the null industry is in the same range as BMXMF (21). This means that BIOQ’s stock grew similarly to BMXMF’s over the last 12 months.

BMXMF's Profit vs Risk Rating (95) in the null industry is in the same range as BIOQ (100). This means that BMXMF’s stock grew similarly to BIOQ’s over the last 12 months.

BIOQ's SMR Rating (5) in the null industry is significantly better than the same rating for BMXMF (72). This means that BIOQ’s stock grew significantly faster than BMXMF’s over the last 12 months.

BMXMF's Price Growth Rating (41) in the null industry is somewhat better than the same rating for BIOQ (85). This means that BMXMF’s stock grew somewhat faster than BIOQ’s over the last 12 months.

BMXMF's P/E Growth Rating (40) in the null industry is somewhat better than the same rating for BIOQ (74). This means that BMXMF’s stock grew somewhat faster than BIOQ’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BIOQBMXMF
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
54%
Stochastic
ODDS (%)
N/A
Bullish Trend 4 days ago
62%
Momentum
ODDS (%)
Bullish Trend 4 days ago
40%
Bullish Trend 4 days ago
52%
MACD
ODDS (%)
Bullish Trend 4 days ago
39%
Bearish Trend 4 days ago
40%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
39%
Bullish Trend 4 days ago
54%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
37%
Bullish Trend 4 days ago
54%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
Bearish Trend 4 days ago
46%
Aroon
ODDS (%)
Bearish Trend 4 days ago
31%
Bullish Trend 4 days ago
58%
View a ticker or compare two or three
Interact to see
Advertisement
BIOQ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BMXMF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CSV46.080.56
+1.23%
Carriage Services
ASTH24.730.01
+0.04%
Astrana Health
ROKU86.50N/A
N/A
Roku
DIST28.00N/A
N/A
Distoken Acquisition Corp
STKH1.48-0.19
-11.38%
Steakholder Foods Ltd

BIOQ and

Correlation & Price change

A.I.dvisor indicates that over the last year, BIOQ has been loosely correlated with VVOS. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if BIOQ jumps, then VVOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIOQ
1D Price
Change %
BIOQ100%
N/A
VVOS - BIOQ
38%
Loosely correlated
-2.67%
USAQ - BIOQ
26%
Poorly correlated
N/A
CSBTF - BIOQ
21%
Poorly correlated
N/A
CHEOY - BIOQ
11%
Poorly correlated
-1.72%
BMXMF - BIOQ
2%
Poorly correlated
N/A
More

BMXMF and

Correlation & Price change

A.I.dvisor tells us that BMXMF and COO have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BMXMF and COO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMXMF
1D Price
Change %
BMXMF100%
N/A
COO - BMXMF
26%
Poorly correlated
+2.08%
SOAGY - BMXMF
24%
Poorly correlated
+1.42%
BRKR - BMXMF
22%
Poorly correlated
-0.90%
MGRM - BMXMF
21%
Poorly correlated
+0.35%
CHEOF - BMXMF
7%
Poorly correlated
N/A
More